Get started

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · 3-min delay · Sign up for real-time

Updates arrive automatically.

  • CACI Advances U.S. Air Force Financial Transparency and Mission Readiness
    PR·

    CACI Advances U.S. Air Force Financial Transparency and Mission Readiness

    CACI International Inc (NYSE:CACI) announced today it has been awarded a five-year, $108 million contract by the U.S. Air Force to advance financial transparency, operational efficiency, and mission readiness. By sustaining and modernizing the Defense Enterprise Accounting and Management System (DEAMS), CACI enables the Air Force to make faster, data-driven decisions and maintain global financial operations with greater precision. "Our technology-first approach delivers advanced automation and decision-quality data that help the Air Force operate more efficiently and maintain mission re

    $CACI
  • Enhanced Provides Clinician-Led Access to Six New Peptides
    PR·

    Enhanced Provides Clinician-Led Access to Six New Peptides

    Prescription-only access through licensed clinicians and U.S. licensed pharmacies begins today Quality-tested ingredients, trained prescribing clinicians and defined clinical protocols Enhanced Group Inc. (NYSE:ENHA) ("Enhanced" or the "Company") today announced that, beginning today, it provides eligible consumers safe and medically supervised access to six peptides through licensed clinicians on the Live Enhanced telehealth platform, following the policy announced by the U.S. Department of Health and Human Services (HHS) on October 28, 2026. Enhanced’s existing peptide offering of GHK-Cu and Sermorelin is now complemented by BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax. All si

    $ENHA
  • Robert Half names DeLynn Senna to Global Executive Director of Permanent Placement
    PR·

    Robert Half names DeLynn Senna to Global Executive Director of Permanent Placement

    Robert Half (NYSE:RHI) has appointed DeLynn Senna to Global Executive Director of Permanent Placement. In this role, Senna is responsible for leading the company's global Permanent Placement strategy and driving growth across all practice groups and markets. During her career at Robert Half, Senna has held leadership positions including Executive Director of Finance and Accounting Permanent Placement, Executive Director of Permanent Placement International Staffing, Senior District Director of Robert Half Legal and most recently, Senior District Director of Global Executive Searc

    $RHI
  • Chegg Reports Third Quarter 2026 Earnings
    PR·

    Chegg Reports Third Quarter 2026 Earnings

    Chegg, Inc. (NYSE:CHGG), a learning and employability company, today reported financial results for the quarter ended September 30, 2026. "Over the last year our focus was rearchitecting our cost structure, accumulating cash, eliminating our debt, and positioning Chegg to return to growth," said Dan Rosensweig, Executive Chairman and CEO of Chegg. "We are evolving Chegg from a homework help company into an employability company, focused on helping people find internships, assess and develop relevant job skills, and secure full-time employment. Our mission is simple; to help people get the jobs they want and build the careers they deserve."

    $CHGG
  • VivoSim Labs and Chemveda Life Sciences Join Forces to Put AI-Designed Drug Candidates to the Human Test
    PR·

    VivoSim Labs and Chemveda Life Sciences Join Forces to Put AI-Designed Drug Candidates to the Human Test

    VivoSim Labs, Inc. (NASDAQ:VIVS) ("VivoSim" or "Company"), a provider of AI-enabled New Approach Methodologies (NAMs) for preclinical safety, and Chemveda Life Sciences ("Chemveda"), an integrated contract research, development and manufacturing organization (CRDMO), today announced a strategic collaboration to test and screen AI-derived drug compounds in VivoSim’s human-relevant NAMkind™ 3D tissue models. Artificial intelligence has changed how fast new drugs can be imagined. Generative models can now propose thousands of novel molecules in the time it once took to design a handful. What has not kept pace is the ability to

    $VIVS
  • Guardant Health Wins 2026 Prix Galien USA Award for Best Medical Technology for Shield Blood Test
    PR·

    Guardant Health Wins 2026 Prix Galien USA Award for Best Medical Technology for Shield Blood Test

    Shield blood test for colorectal cancer (CRC) recognized for impact in increasing screening participation for CRC and closing today’s screening gaps Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, announced it received the 2026 Prix Galien USA Award for Best Medical Technology for Shield™, the leading blood test for colorectal cancer (CRC) detection and first to receive FDA approval for primary CRC screening, for its achievements in expanding patient choice and increasing screening participation for CRC. Established in 2007, the Prix Galien USA Awards recognize the leading scientific advances in life sciences that contribute to improving human health worldwide

    $GH
  • ConnectM Appoints Industry Veteran Karl Pomeroy as President of Keen Labs to Scale Commercial Growth
    PR·

    ConnectM Appoints Industry Veteran Karl Pomeroy as President of Keen Labs to Scale Commercial Growth

    ConnectM Technology Solutions, Inc. (OTCQX:CNTM) ("ConnectM" or the "Company"), a U.S.-based technology company that develops, sells and operates energy infrastructure powering the physical layer of the AI economy, today announced the appointment of Karl Pomeroy as President of Keen Labs, the Company’s wholly owned technology subsidiary, effective November 2, 2026. Mr. Pomeroy brings more than 35 years of executive leadership experience at the intersection of thermal, energy, and tech industries, including expanding national distribution and service networks, advancing electrification initiatives, and driving profitable growth. Mr. Pom

    $CNTM
  • Sysco Reports First Quarter 2027 Results; Reiterates FY27 Adjusted EPS and Local Volume Guidance
    PR·

    Sysco Reports First Quarter 2027 Results; Reiterates FY27 Adjusted EPS and Local Volume Guidance

    Sysco Corporation (NYSE:SYY) ("Sysco" or the "company") today announced financial results for its 13-week first fiscal quarter ended September 26, 2026. Key financial results for the first quarter of fiscal year 2027 include the following (comparisons are to the same period in fiscal year 2026): Sales increased 2.8%; U.S. Foodservice volume increased 2.6%; U.S. Foodservice local volume increased 2.7%;Gross profit increased 3.8% to $4.1 billion;Operating income decreased 10.4% to $717 million, and adjusted operating income increased 3.2% to $927 million1;Net earnings increased 10.5% to $526 million, and adjusted net earnings increased 4.2% to $57

    $SYY
  • Alto Neuroscience Announces Participation in Upcoming Investor Conferences
    PR·

    Alto Neuroscience Announces Participation in Upcoming Investor Conferences

    Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will participate in the following upcoming investor conferences:Stifel 2026 Healthcare Conference, November 10-12, 2026Format: Fireside chat and one-on-one meetingsPresentation Date & Time: Wednesday, November 11 at 8:00 AM ETLocation: New York, New YorkJefferies London Healthcare Conference, November 16-19, 2026Format: Fireside chat and one-on-one investor meetingsPresentation Date & Time: Thursday, November 19 at 9:30 AM GMTLocation: London, UKThe present

    $ANRO
  • Sysco Names Brandon Sewell Chief Financial Officer
    PR·

    Sysco Names Brandon Sewell Chief Financial Officer

    Sysco Corporation (NYSE:SYY) ("Sysco" or the "company") today announced that Brandon Sewell, the Company’s Interim Chief Financial Officer since March 2026, has been named Executive Vice President and Chief Financial Officer, effective November 1, 2026. "Brandon has distinguished himself as a trusted and highly effective leader throughout his twelve years with the company, and when asked to step in as Interim Chief Financial Officer, he performed at a high level," said Kevin Hourican, Sysco’s Chair of the Board and Chief Executive Officer. "Brandon commands a deep knowledge of our business, broad financial expertise, and strong understanding of h

    $SYY
  • TransUnion Named One of TIME's America's Best Companies of 2026
    PR·

    TransUnion Named One of TIME's America's Best Companies of 2026

    TransUnion (NYSE:TRU) today announced it has been named to TIME’s America’s Best Companies 2026 list, a recognition that identifies the top-performing companies in the United States based on employee satisfaction, financial performance and sustainability transparency. TransUnion helps enable trust between consumers and businesses in areas such as credit, fraud prevention, marketing and consumer solutions. Decades of responsible data stewardship and continued investment in technology and innovation have allowed the company to expand beyond traditional credit reporting while maintaining a strong focus on ensuring consumers and organizations transac

    $TRU
  • Core Molding Technologies Reports Fiscal 2026 Third Quarter Results
    PR·

    Core Molding Technologies Reports Fiscal 2026 Third Quarter Results

    Core Molding Technologies, Inc. (NYSE:CMT) ("Core Molding", "Core" or the "Company"), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty truck, powersports, building products, and industrial and utilities industries across the United States, Canada and Mexico today reports financial and operating results for the fiscal periods ended September 30, 2026. Eric Palomaki, the Company’s President and Chief Executive Officer, said, "Our third quarter results reflect continued progress against our strategic initiatives that will shape our next phase of growth. While the quarter

    $CMT
  • Innventure to Announce Third Quarter 2026 Results on November 12, 2026
    PR·

    Innventure to Announce Third Quarter 2026 Results on November 12, 2026

    Innventure, Inc. (NASDAQ:INV) ("Innventure") today announced it will release its third quarter 2026 financial results after market close on Thursday, November 12, 2026. Management will host a conference call on the day of the release at 5:00 pm ET to discuss the results. The event will be webcast live via our investor relations website https://www.innventure.com/investors or via this link. A replay of the event webcast will be made available on Innventure’s Investor Relations website following the call. About InnventureInnventure (NASDAQ:INV) builds and scales the companies that it has founded as they commercialize new technologies. Innve

    $INV
  • Global-e to Announce Financial Results for the Third Quarter 2026 on November 18, 2026
    PR·

    Global-e to Announce Financial Results for the Third Quarter 2026 on November 18, 2026

    Global-e Online Ltd. (NASDAQ:GLBE), ), the leading global e-commerce enablement platform powering the world's most iconic brands, today announced it will report financial results for the third quarter ended September 30, 2026, before market open on Wednesday, November 18, 2026. Global-e management will host a conference call to review its financial results and outlook. Date:Wednesday, November 18, 2026Time:8:00 AM ETUnited States/Canada Toll Free:+1-800-717-1738International Toll:+1-646-307-1865 Please join the call 5-10 minutes prior to the scheduled start time, to avoid a delay in connecting. A live webcast will be available in th

    $GLBE
  • LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026
    PR·

    LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026

    LENSAR, Inc. (NASDAQ:LNSR) ("LENSAR" or the "Company"), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company’s third quarter 2026 financial results will be released before market open on Tuesday, November 10, 2026. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Tuesday, November 10, 2026 to discuss the results and recent operational highlights. To participate by telephone, please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call. T

    $LNSR